Summary

As there is little current information on the prevalence of resistance among Shigella isolated in New Zealand, this pilot project aimed to examine the antimicrobial susceptibilities of recent isolates of Shigella. A total of 107 isolates were referred to ESR Communicable Disease Centre in January to June 1996. All isolates were serotyped, biotyped and tested for susceptibility to ampicillin, ciprofloxacin, amoxicillin/clavulanic acid, tetracycline and TMP-SMZ by an agar dilution method.